Braavos Capital

Braavos Investment Advisers operates as a London-based venture capital firm focused on early to growth-stage companies. It provides capital, extensive networks, and strategic talent to support enterprises built upon scientific and technological breakthroughs. The firm demonstrates a particular interest in innovations emanating from leading research institutions, notably the University of Oxford, leveraging deep academic expertise to identify and foster promising ventures.

The firm was established around late 2019 by co-founders Magda Wierzycka and Andre Crawford-Brunt. Magda Wierzycka brings a significant track record as the co-founder and CEO of Sygnia Ltd, a prominent financial services firm. Their founding insight centered on the critical need to bridge the gap between groundbreaking scientific discoveries and their commercial application, empowering visionary founders to translate complex research into viable solutions.

Braavos Investment Advisers partners with science and technology companies aiming to commercialize advanced research. The firm's overarching mission is to build enterprises that address humanity's pressing challenges, striving for tangible impact through innovation. They envision a future where scientific breakthroughs are effectively nurtured and scaled to deliver lasting, transformative solutions globally.